First SCRA use (n = 82) | Reasons for SCRA use n, % | Most important reason n, % | ||
---|---|---|---|---|
Curiosity to compare effects to cannabis | 63 | 77% | 18 | 22% |
Offered by others/available | 51 | 62% | 15 | 18% |
Heard reports from other sources | 50 | 61% | 7 | 9% |
Offered an alternative to cannabis | 42 | 51% | 13 | 16% |
Legal status | 42 | 51% | 10 | 12% |
Easier to obtain than cannabis | 31 | 38% | 4 | 5% |
Subject to drug testing | 20 | 24% | 7 | 9% |
To reduce or cease cannabis use | 15 | 18% | 6 | 7% |
Produced desirable recreational effects | 14 | 17% | - | - |
Less expensive than cannabis | 10 | 12% | 1 | 1% |
Stronger than cannabis | 10 | 12% | 1 | 1% |
Produced positive therapeutic/medicinal effects | 7 | 9% | - | - |
Milder than cannabis | 4 | 5% | - | - |
Subsequent SCRA use (n = 72) | ||||
Offered an alternative to cannabis | 37 | 51% | 7 | 10% |
Easier to obtain than cannabis | 34 | 47% | 7 | 10% |
Stronger than cannabis | 33 | 44% | 13 | 18% |
Legal status | 31 | 43% | 7 | 10% |
Offered by others/available | 31 | 43% | 9 | 13% |
Produced desirable recreational effects | 22 | 31% | 6 | 8% |
Subject to drug testing | 20 | 28% | 9 | 13% |
Curiosity to compare effects to cannabis | 19 | 26% | 9 | 13% |
Produced positive therapeutic/medicinal effects | 10 | 14% | - | - |
Less expensive than cannabis | 9 | 13% | 3 | 4% |
To reduce or cease cannabis use | 8 | 11% | 2 | 3% |
Heard reports from other sources | 8 | 11% | - | - |
Milder than cannabis | 5 | 7% | - | - |
No SCRA use (n = 72) | ||||
Heard bad/negative reports | 62 | 86% | 37 | 51% |
Not a natural product | 50 | 69% | 17 | 24% |
No curiosity to try SCRAs | 40 | 56% | 5 | 7% |
Undesired recreational effects | 38 | 53% | 7 | 10% |
Distrust of SCRA manufacturers | 20 | 28% | 2 | 3% |
Never offered or available | 14 | 19% | 4 | 6% |
Negative/harmful effect profile | 14 | 19% | - | - |
Distrust of SCRA retailers | 11 | 15% | - | - |
Illegal status | 9 | 13% | - | - |
More difficult to obtain | 8 | 11% | - | - |
Stronger than cannabis | 5 | 7% | - | - |
Subject to drug testing | 3 | 4% | - | - |
More expensive | 2 | 3% | - | - |
Milder than cannabis | 2 | 3% | - | - |